The role of reproductive hormones in postpartum depression
- PMID: 25263255
- PMCID: PMC4363269
- DOI: 10.1017/S1092852914000480
The role of reproductive hormones in postpartum depression
Abstract
Despite decades of research aimed at identifying the causes of postpartum depression (PPD), PPD remains common, and the causes are poorly understood. Many have attributed the onset of PPD to the rapid perinatal change in reproductive hormones. Although a number of human and nonhuman animal studies support the role of reproductive hormones in PPD, several studies have failed to detect an association between hormone concentrations and PPD. The purpose of this review is to examine the hypothesis that fluctuations in reproductive hormone levels during pregnancy and the postpartum period trigger PPD in susceptible women. We discuss and integrate the literature on animal models of PPD and human studies of reproductive hormones and PPD. We also discuss alternative biological models of PPD to demonstrate the potential for multiple PPD phenotypes and to describe the complex interplay of changing reproductive hormones and alterations in thyroid function, immune function, hypothalamic-pituitary-adrenal (HPA) axis function, lactogenic hormones, and genetic expression that may contribute to affective dysfunction. There are 3 primary lines of inquiry that have addressed the role of reproductive hormones in PPD: nonhuman animal studies, correlational studies of postpartum hormone levels and mood symptoms, and hormone manipulation studies. Reproductive hormones influence virtually every biological system implicated in PPD, and a subgroup of women seem to be particularly sensitive to the effects of perinatal changes in hormone levels. We propose that these women constitute a "hormone-sensitive" PPD phenotype, which should be studied independent of other PPD phenotypes to identify underlying pathophysiology and develop novel treatment targets.
Keywords: postpartum depression.
Conflict of interest statement
Disclosure of Commercial and Non-Commercial Interests
The authors do not have an affiliation with or financial interest in any organization that might pose a conflict of interest.
Similar articles
-
Allopregnanolone as a mediator of affective switching in reproductive mood disorders.Psychopharmacology (Berl). 2014 Sep;231(17):3557-67. doi: 10.1007/s00213-014-3599-x. Epub 2014 May 21. Psychopharmacology (Berl). 2014. PMID: 24846476 Free PMC article. Review.
-
Prenatal Exposure to Bisphenols and Phthalates and Postpartum Depression: The Role of Neurosteroid Hormone Disruption.J Clin Endocrinol Metab. 2021 Jun 16;106(7):1887-1899. doi: 10.1210/clinem/dgab199. J Clin Endocrinol Metab. 2021. PMID: 33792735 Free PMC article.
-
[GABAergic approach of postpartum depression: A translational review of literature].Encephale. 2020 Apr;46(2):123-134. doi: 10.1016/j.encep.2019.09.007. Epub 2019 Nov 22. Encephale. 2020. PMID: 31767256 French.
-
Biological aspects of postpartum depression.Womens Health (Lond). 2012 Nov;8(6):659-72. doi: 10.2217/whe.12.55. Womens Health (Lond). 2012. PMID: 23181531 Review.
-
New insights into the role of perinatal HPA-axis dysregulation in postpartum depression.Neuropeptides. 2013 Dec;47(6):363-70. doi: 10.1016/j.npep.2013.10.007. Epub 2013 Oct 23. Neuropeptides. 2013. PMID: 24210135 Review.
Cited by
-
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions.Drugs. 2024 Jun;84(6):645-659. doi: 10.1007/s40265-024-02038-z. Epub 2024 May 30. Drugs. 2024. PMID: 38811474 Review.
-
Prolonged HPA axis dysregulation in postpartum depression associated with adverse early life experiences: A cross-species translational study.Nat Ment Health. 2024 May;2(5):593-604. doi: 10.1038/s44220-024-00217-1. Epub 2024 Apr 11. Nat Ment Health. 2024. PMID: 38736646 Free PMC article.
-
Exploring patterns in mental health treatment and interests of single adults in the United States: a secondary data analysis.Front Public Health. 2024 Apr 22;12:1292603. doi: 10.3389/fpubh.2024.1292603. eCollection 2024. Front Public Health. 2024. PMID: 38711766 Free PMC article.
-
Exploring the Efficacy of Ketamine as an Anesthetic and Antidepressant in Postpartum Depression: A Case Study Analysis.Cureus. 2024 Feb 29;16(2):e55208. doi: 10.7759/cureus.55208. eCollection 2024 Feb. Cureus. 2024. PMID: 38558697 Free PMC article.
-
Genome-wide association study of early-onset and late-onset postpartum depression: the IGEDEPP prospective study.Eur Psychiatry. 2024 Apr 1;67(1):1-36. doi: 10.1192/j.eurpsy.2024.26. Online ahead of print. Eur Psychiatry. 2024. PMID: 38555957 Free PMC article.
References
-
- Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005;106(5 Pt 1):1071–83. - PubMed
-
- Hendrick V, Altshuler LL, Suri R. Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics. 1998;39(2):93–101. - PubMed
-
- Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000;157(10831472):924–930. - PubMed
-
- Galea LA, Wide JK, Barr AM. Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res. 2001;122(1):1–9. - PubMed
-
- Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347(9006):930–933. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical